Swati Irani

529 total citations
11 papers, 283 citations indexed

About

Swati Irani is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Swati Irani has authored 11 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Swati Irani's work include Prostate Cancer Treatment and Research (6 papers), Cancer, Lipids, and Metabolism (4 papers) and Hormonal and reproductive studies (3 papers). Swati Irani is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Cancer, Lipids, and Metabolism (4 papers) and Hormonal and reproductive studies (3 papers). Swati Irani collaborates with scholars based in Australia, Japan and United States. Swati Irani's co-authors include Lisa M. Butler, Margaret M. Centenera, David J. Lynn, Max Moldovan, Zeyad D. Nassar, Luke A. Selth, Andrew J. Hoy, Lisa G. Horvath, Chui Y. Mah and Raj K. Shrestha and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Swati Irani

11 papers receiving 281 citations

Peers

Swati Irani
Jiaju Xu China
Swati Irani
Citations per year, relative to Swati Irani Swati Irani (= 1×) peers Jiaju Xu

Countries citing papers authored by Swati Irani

Since Specialization
Citations

This map shows the geographic impact of Swati Irani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swati Irani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swati Irani more than expected).

Fields of papers citing papers by Swati Irani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swati Irani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swati Irani. The network helps show where Swati Irani may publish in the future.

Co-authorship network of co-authors of Swati Irani

This figure shows the co-authorship network connecting the top 25 collaborators of Swati Irani. A scholar is included among the top collaborators of Swati Irani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swati Irani. Swati Irani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Gillis, Joanna L., Chui Y. Mah, Swati Irani, et al.. (2023). Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer. British Journal of Cancer. 129(8). 1350–1361. 7 indexed citations
2.
Gillis, Joanna L., Natalie K. Ryan, Swati Irani, et al.. (2021). A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth. eLife. 10. 26 indexed citations
3.
Nassar, Zeyad D., Chui Y. Mah, Margaret M. Centenera, et al.. (2020). Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. Molecular Cancer Research. 18(10). 1500–1511. 19 indexed citations
4.
Nassar, Zeyad D., Chui Y. Mah, Jonas Dehairs, et al.. (2020). Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis. eLife. 9. 140 indexed citations
5.
Tieu, Terence, Swati Irani, Natalie K. Ryan, et al.. (2020). Patient‐Derived Prostate Cancer Explants: A Clinically Relevant Model to Assess siRNA‐Based Nanomedicines. Advanced Healthcare Materials. 10(6). e2001594–e2001594. 18 indexed citations
6.
Trim, Paul J., Bala Krishna Prabhala, Swati Irani, et al.. (2019). Evaluation of Small Molecule Drug Uptake in Patient-Derived Prostate Cancer Explants by Mass Spectrometry. Scientific Reports. 9(1). 15008–15008. 13 indexed citations
7.
Butler, Lisa M., Swati Irani, Margaret M. Centenera, et al.. (2019). Preclinical investigation of a small molecule inhibitor of p300/CBP reveals efficacy in patient-derived prostate tumor explants.. Journal of Clinical Oncology. 37(15_suppl). e16534–e16534. 2 indexed citations
8.
Irani, Yazad, et al.. (2019). Sex differences in corneal neovascularization in response to superficial corneal cautery in the rat. PLoS ONE. 14(9). e0221566–e0221566. 7 indexed citations
9.
Gyawali, Prabin, Luke A. Selth, Lisa M. Butler, et al.. (2019). Sex hormone-binding globulin (SHBG) as a marker of aggressive prostate cancer. Endocrine Abstracts. 1 indexed citations
10.
Nguyen, Elizabeth V., Margaret M. Centenera, Max Moldovan, et al.. (2018). Identification of Novel Response and Predictive Biomarkers to Hsp90 Inhibitors Through Proteomic Profiling of Patient-derived Prostate Tumor Explants. Molecular & Cellular Proteomics. 17(8). 1470–1486. 26 indexed citations
11.
Armstrong, Heather, Yen Chin Koay, Swati Irani, et al.. (2016). A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response. The Prostate. 76(16). 1546–1559. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026